The possible role of PCSK9 inhibitors in cardiac syndrome X: Bridging microvascular dysfunction, endothelial pathobiology, and molecular pharmacotherapy

Microvascular Research 2026

View at publisher

Authors: Sherouk Hussein Sweilam, Hayder Mutter Al-Kuraishy, Aya M. Mustafa, Shaimaa M. Hassan, Reem Alsharari, Gaber El-Saber Batiha

DOI: 10.1016/j.mvr.2026.104925

Cited by: 1

References: 89

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Peripheral Artery Disease Management Atherosclerosis and Cardiovascular Diseases

References 89